You are here Home Resources and guidance Sponsors The Medicines Company Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type Cancellation by sponsor (1) Date 2018 (1) Search Sponsor content1 result(s) found, displaying 1 to 1 ANGIOMAX bivalirudin 100mg (as trifluoroacetate) powder for injection vial Cancelled under s30(1)(c) of the Act 16 January 2018 Cancellation by sponsor Requested by The Medicines Company Australia Pty Ltd
ANGIOMAX bivalirudin 100mg (as trifluoroacetate) powder for injection vial Cancelled under s30(1)(c) of the Act 16 January 2018 Cancellation by sponsor Requested by The Medicines Company Australia Pty Ltd